Inmaculada C. Sorribes, PhD (she/her/hers)

Associate Director
Quantitative Pharmacology and Pharmacometrics Immune/Oncology (QP2-I/O), Merck & Co., Inc., Rahway, New Jersey, USA

Poster(s):

• (W-116) Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
  Wednesday, November 13, 2024

  7:00 AM – 1:45 PM MST